a developer of molecular technology products
Industry MedicalSpecialties
A.I.dvisor tells us that ENZ and SINT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZ and SINT's prices will move in lockstep.
Ticker / NAME | Correlation To ENZ | 1D Price Change % | ||
---|---|---|---|---|
ENZ | 100% | N/A | ||
SINT - ENZ | 26% Poorly correlated | +0.92% | ||
ANIK - ENZ | 24% Poorly correlated | -0.23% | ||
BLOZF - ENZ | 24% Poorly correlated | -15.69% | ||
SGHT - ENZ | 22% Poorly correlated | -3.02% | ||
MYNZ - ENZ | 22% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To ENZ | 1D Price Change % |
---|---|---|
ENZ | 100% | N/A |
molecular technology theme (2 stocks) | 17% Poorly correlated | -3.77% |
drugs theme (254 stocks) | 13% Poorly correlated | -1.67% |
stem cells theme (21 stocks) | 4% Poorly correlated | -3.36% |
Medical Specialties theme (427 stocks) | -0% Poorly correlated | -1.35% |
Medical Specialties theme (417 stocks) | -0% Poorly correlated | -1.54% |
More |